PYC Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

ASX:PYC Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
31 Aug 26	SellAU$10,789,833	The Retail Employees Superannuation Trust	Company	4,711,473	AU$2.32
30 Jul 26	BuyAU$692,894	The Retail Employees Superannuation Trust	Company	522,672	AU$1.67
12 Jun 26	BuyAU$63,868,489	The Retail Employees Superannuation Trust	Company	49,500,193	AU$1.29
24 Mar 26	BuyAU$99,883	Rohan Hockings	Individual	82,550	AU$1.21
06 Mar 26	BuyAU$120,015	Rohan Hockings	Individual	80,010	AU$1.50
06 Mar 26	BuyAU$184,500	Ian Constable	Individual	123,000	AU$1.50
20 Feb 26	BuyAU$79,051,249	Firetrail Investments Pty Ltd	Company	53,082,328	AU$1.49
11 Feb 26	BuyAU$125,774,923	RA Capital Management, L.P.	Company	83,850,000	AU$1.50
26 Nov 25	BuyAU$200,003	Rohan Hockings	Individual	133,350	AU$1.50
19 Nov 25	BuyAU$9,406,068	Mccusker Holdings Pty. Ltd.	Company	7,327,200	AU$1.36
05 Nov 25	BuyAU$10,244,437	Firetrail Investments Pty Ltd	Company	8,450,533	AU$1.21
05 Nov 25	SellAU$1,668,022	Firetrail Investments Pty Ltd	Company	1,364,743	AU$1.22

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of PYC?
Owner Type	Number of Shares	Ownership Percentage
Private Companies	46,517,929	4.73%
VC/PE Firms	83,850,000	8.53%
Institutions	119,897,801	12.2%
Individual Insiders	223,877,547	22.8%
General Public	509,367,170	51.8%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 68.6%.

Top Shareholders

Top 25 shareholders own 48.19% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
19%	Alan Tribe	186,726,741	AU$451.9m	0%	no data
8.53%	RA Capital Management, L.P.	83,850,000	AU$202.9m	0%	1.22%
4.61%	The Retail Employees Superannuation Trust	45,311,392	AU$109.7m	-8.46%	12.51%
3.61%	Firetrail Investments Pty Ltd	35,534,882	AU$86.0m	20.5%	4.98%
2.78%	Mccusker Holdings Pty. Ltd.	27,363,600	AU$66.2m	0%	no data
1.72%	David Sietsma	16,875,000	AU$40.8m	0%	no data
1.05%	Wilson Asset Management (International) Pty Ltd.	10,309,283	AU$24.9m	0%	0.55%
0.92%	Datamatch Pty Ltd	9,000,000	AU$21.8m	0%	no data
0.86%	Andbank Asset Management Luxembourg SA	8,495,932	AU$20.6m	0%	8.14%
0.84%	Adrian Bonaddio	8,249,561	AU$20.0m	0%	no data
0.71%	BlackRock, Inc.	7,001,673	AU$16.9m	182%	no data
0.65%	John Baird	6,400,266	AU$15.5m	0%	no data
0.54%	Masali Pty. Ltd.	5,334,329	AU$12.9m	0%	no data
0.51%	Adam Bonaddio	5,002,069	AU$12.1m	0%	no data
0.49%	Selwood Barton Pty Ltd	4,820,000	AU$11.7m	0%	no data
0.43%	McCusker Charitable Foundation	4,200,000	AU$10.2m	0%	61.82%
0.35%	Vanguard Capital Management, LLC	3,480,169	AU$8.4m	0%	no data
0.33%	Fidelity International Ltd	3,287,691	AU$8.0m	0%	no data
0.11%	Vanguard Investments Australia Limited	1,094,300	AU$2.6m	0%	no data
0.038%	Vanguard Asset Management, Limited	374,894	AU$907.3k	0%	no data
0.033%	Ian Constable	328,000	AU$793.8k	0%	no data
0.03%	Rohan Hockings	295,910	AU$716.2k	0%	no data
0.029%	Manulife Asset Management	285,885	AU$691.9k	0%	no data
0.024%	Dimensional Fund Advisors LP	236,445	AU$572.2k	0%	no data
0.012%	KLP Kapitalforvaltning AS	117,012	AU$283.2k	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/09/10 08:49
End of Day Share Price	2026/09/10 00:00
Earnings	2026/06/30
Annual Earnings	2026/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

PYC Therapeutics Limited is covered by 7 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Melissa Benson	Barrenjoey Markets Pty Limited
Thomas Wakim	Bell Potter
David Martin	Bloom Burton & Co.